In a tumour cell reconstituted recombinant system, the inhibitor of mitochondrial transcription (IMTs), which specifically targets POLRMT, significantly hampers mitochondrial DNA (mtDNA) transcription and triggers the dose-dependent inhibition of mtDNA expression and the oxidative phosphorylation system [17]. Here, POLRMT is linked to neoplasm.